Industry Analysis--Changing Dynamics in Worldwide Psychiatric Franchises

Table of Contents

• Executive Summary
• Strategic Considerations
• Stakeholder Implications
• Overview
• Psychiatric Diseases
• Worldwide Psychiatric Markets-Top Brands
• Major Psychiatric Franchises
• Big Pharma Franchises
• AstraZeneca
• GlaxoSmithKline
• Eli Lilly
• Johnson & Johnson
• Novartis
• Pfizer
• Sanofi-Aventis
• Wyeth
• Midsize Pharma Franchises
• Generics Franchises
• Recent Psychiatric Deals
• Outlook

Figures

• 1. Total Prevalent Cases of Select Patient Populations, 2006
• 2. Blockbuster Psychiatric Drugs, 2005
• 3. Major Worldwide Psychiatric Franchises-Big and Midsize Pharma, 2005
• 4. Worldwide Generics Psychiatric Franchises, 2005
• 5. Genotype-Based Drug Doses for Antidepressants

Tables

• 1. Select Psychiatric Deals, 2005-2006